Cargando…
Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization
Some fluoroquinazolinones (A–H) were designed, synthesized and biologically evaluated for their antitumor activity against the two cell lines, MCF-7 and MDA-MBA-231. New derivative G (IC(50) = 0.44 ± 0.01 µM) showed antitumor activity, better than that of the reference drug erlotinib (IC(50) = 1.14...
Autores principales: | Zayed, Mohamed F., Rateb, Heba S., Ahmed, Sahar, Khaled, Osama A., Ibrahim, Sabrin R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100557/ https://www.ncbi.nlm.nih.gov/pubmed/30002297 http://dx.doi.org/10.3390/molecules23071699 |
Ejemplares similares
-
Design, Synthesis, Cytotoxic Evaluation and Molecular Docking of New Fluoroquinazolinones as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Zayed, Mohamed F., et al.
Publicado: (2018) -
The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization
por: Ihmaid, Saleh, et al.
Publicado: (2018) -
Targeting EGFR Tyrosine Kinase: Design, Synthesis and Biological Evaluation of Novel Quinazolinone Derivatives
por: Nematpour, Manijeh, et al.
Publicado: (2022) -
Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Alswah, Mohamed, et al.
Publicado: (2017) -
Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids
por: Auti, Prashant S., et al.
Publicado: (2020)